Figure 1From: Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemiamRNA expression levels of BDH2 in bone marrow. BDH2 mRNA expression levels in bone marrow from patients with normal bone marrow and cytogenetically normal AML (CN-AML). P<0.001. Higher ΔCT-BDH2 means lower mRNA expression levels. BM: bone marrow. Sample number of bone marrows from normal bone marrow and CN-AML are 43 and 113.Back to article page